Vaccine for Cancer

FDA panel supports using Gardasil to prevent anal cancer in males, females between 9 and 26.
The AP (11/18) reports, "A federal health panel says evidence supports expanding use of Merck's Gardasil (Recombinant Human Papillomavirus Quadrivalent) vaccine to prevent anal cancer in young men and women." An FDA panel said "a 4,000-patient study conducted by Merck & Co. Inc. shows the vaccine lowers the risk of anal cancer in men. They said these results can also be applied to women." WebMD (11/18, McMillen) and MedPage Today (11/18) also report the story.